Manufacturer and distributer of pediatric rehab products designed for children with special needs. Products include adaptive chairs, special needs car seats, standers, desks, bathing chairs, toileting chairs, special needs strollers, walkers, adapted tricycles, and therapeutic products designed for use in the classroom, clinic or home
Provides special utensils and products for children with feeding and oral motor disorders including the Johnson Therapeutic Textured Spoon, shallow bowls and utensils that provide oral-sensory stimulation with feeding
Custom-builds mobility devices for individuals with disabilities such as Cerebral Palsy, Spina Bifida, Muscular Dystrophy, Angelman Syndrome, Rett Syndrome, and visually impaired. Freedom Concepts Inc. (FCI) custom designed tricycles, walkers and chairs provide mobility and therapeutic benefits for thousands of special needs individuals throughout Canada and the U.S.
U.S. Department of Health &Human Services - Agency for Healthcare Research and Quality. The mission of CERTs is to conduct research and provide education that will advance the optimal use of drugs, medical devices, and biological products; increase awareness of the benefits and risks of therapeutics; and improve quality while cutting the costs of care. CERTs consists of 14 research centers and a Coordinating Center. The Centers receive funds from both public and private sources, with core financial support from the Agency for Healthcare Research and Quality (AHRQ).
Constraint-Induced Movement Therapy (CIT) is a recent therapeutic intervention for people with hemiplegia involving restraint of the non-involved extremity and structured practice with the more affected extremity. CIT involves restraint of the less affected extremity of children with
hemiplegic cerebral palsy, along with practice with the more affected extremity.
Developer and manufacturer of sensory integration dysfunction (DSI) and neurodevelopmental products that help therapeutic professionals, people with special needs, their families, and other professionals, solve problems or meet new challenges.
Stanford trial assessing use of Theta-burst transcranial magnetic stimulation (TBS) as a new, non-invasive therapeutic intervention to aid in physical therapy and symptom amelioration of dystonia and spasticity
Clinical Chemistry - 1997 NACB Symposium - Evaluation of the newborn's blood gas status - This paper discusses considerations for interpretation of blood gases in the newborn period. Blood gas measurements and noninvasive estimations provide important information about oxygenation. Its determined that Blood gas measurements and complementary, noninvasive monitoring techniques provide the clinician with information essential to patient assessment, therapeutic decision making, and prognostication. Blood gas measurements are as important for ill newborn infants as for other critically ill patients, but unique challenges are provided by rapidly changing physiology, difficult access to arterial and mixed venous sampling sites, and small blood volumes.
Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats. Hypoxia-ischemia (HI), as a major cause of fetal brain damage, has long-lasting neurological implications. Therefore, therapeutic interventions that attenuate
the neuropathological out come of HI while also improving the neurofunctional outcome are of paramount clinical importance. The aim of this study was to investigate the long-term functional and protective actions of granulocyte-colony stimulating factor (G-CSF) treatment in an experimental model of cerebral. RESULTS: Granulocyte-colony stimulation promoted somatic growth and prevented brain atrophy and underdevelopment of the heart in infant rats.
Theta-burst transcranial magnetic stimulation (TBS) is a type of repetitive transcranial magnetic stimulation (rTMS) method that reduces the excitability of a small region of brain for less than one hour. Since dystonia and spasticity may be associated with increased excitability of motor cortex, we expect that by reducing the excitability of motor cortex with TBS we will temporarily improve these symptoms and hopefully open avenues in the future for the use of TBS as a new, non-invasive therapeutic intervention to aid in physical therapy and symptom amelioration of dystonia and spasticity.
Study being conducted to identify specific motor signatures of different forms of dystonia. Study will examine abnormal co-activation in distal and proximal muscles to evaluate the characteristics of the loss of selectivity of the motor command in mobile vs. fixed dystonia. We will also study possible cognitive and limbic components of the disease, examining the influence of cognitive and emotional loads on movement production.
Provides products designed specifically for special needs children. Founded by a parent, a Pediatric Physical Therapist, an engineer and an industrial designer, manufacturer in response to requests for a simple, durable line of products that work for kids and parents with special needs.
Reprint from ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, Vol. 70. January 1989 - Spasticity: Quantitative Measurements as a Basis for Assessing Effectiveness of Therapeutic Intervention
NCBI PubMed Abstract, Department of Pediatrics, University of Tennessee Study involving piglets to determine whether the generation of superoxide anion occurs primarily during asphyxia or whether reventilation must take place, 2) to investigate the effects of indomethacin pretreatment at a therapeutic dose of 0.2 mg/kg i.v. on superoxide anion generation, and 3) to investigate the effects of oxypurinol, an oxygen free radical scavenger, on superoxide anion production during asphyxia/reventilation